Iamgold
IAG
18.03
-0.52
-2.80%
Iamgold
US · IAG
#1422 by market cap
Listed 1970
18.03
-0.52
-2.80%
Live - 5344 symbols - heartbeat 228s ago
· 2026-10-08 08:30
Pre-market
18.15
+0.67%
After-hours
18.08
+0.28%
Overnight
18.00
-0.17%
- Market cap
- 10.30B
- P/E (TTM)i
- 9.11
- P/Bi
- 2.34
- EPSi
- 1.14
- Div yieldi
- 0.00%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on IAG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.25, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +74.70% YoY
Margins
- Gross margin
- 42.28%
- Operating margin
- 38.92%
- Net margin
- 23.29%
Key ratios & quality
- Enterprise valuei
- 10.55B
- Altman Z-Scorei
- 5.25
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.11B | 1.07B | 1.24B | 875.50M | 958.80M | 987.10M | 1.63B | 2.85B |
| Gross profit | 136.90M | 69.60M | 250.30M | 62.20M | 147.90M | 124.10M | 549.90M | 1.21B |
| Selling & admin expenses | 44.20M | 47.10M | 44.90M | 39.60M | 51.10M | 46.90M | 43.50M | 55.30M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 42.90M | -40.70M | 147.30M | -79.50M | 55.20M | 29.00M | 492.40M | 1.11B |
| Pretax profit | 15.10M | -328.30M | 98.80M | -54.50M | 41.70M | 128.20M | 977.20M | 969.80M |
| Tax | 38.00M | 30.40M | 44.10M | 33.40M | 78.10M | 30.70M | 129.40M | 237.50M |
| Net profit | -19.70M | -398.00M | 58.80M | -255.10M | -52.80M | 103.80M | 847.80M | 732.30M |
| Basic EPS | 0 | -1 | 0 | -1 | 0 | 0 | 2 | 1 |
| Diluted EPS | -0.06 | -0.88 | 0.09 | -0.53 | -0.15 | 0.19 | 1.50 | 1.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 477.10M | 580.90M | 706.70M | 1.09B | 1.03B | 856.90M |
| Gross profit | 141.20M | 198.80M | 272.60M | 593.60M | 570.70M | 415.10M |
| Selling & admin expenses | 16.40M | 12.50M | 14.60M | 11.80M | 15.40M | 21.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 112.20M | 177.60M | 251.30M | 566.80M | 544.70M | 386.10M |
| Pretax profit | 85.70M | 164.80M | 199.60M | 519.70M | 533.80M | 365.10M |
| Tax | 39.20M | 78.90M | 44.40M | 75.00M | 116.40M | 109.30M |
| Net profit | 46.50M | 85.90M | 155.20M | 444.70M | 417.40M | 255.80M |
| Basic EPS | 0 | 0 | 0 | 1 | 1 | 0 |
| Diluted EPS | 0.07 | 0.14 | 0.24 | 0.70 | 0.64 | 0.40 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.09B | 1.26B | 1.40B | 951.10M | 1.52B | 753.70M | 668.30M | 903.70M |
| Cash & ST investments | 734.60M | 841.20M | 947.50M | 552.50M | 407.80M | 367.10M | 348.50M | 422.90M |
| Inventory | 274.70M | 308.50M | 327.30M | 302.10M | 199.90M | 266.30M | 271.90M | 377.00M |
| Total assets | 3.96B | 3.86B | 4.15B | 3.97B | 4.43B | 4.54B | 5.37B | 5.85B |
| Total current liabilities | 227.20M | 266.00M | 334.80M | 581.70M | 646.20M | 630.80M | 550.60M | 517.10M |
| Short-term debt | 2.20M | 18.00M | 25.90M | 28.90M | 13.80M | 26.10M | 29.80M | 33.30M |
| Long-term debt | 398.50M | 403.90M | 458.70M | 456.90M | 910.00M | 825.80M | 1.03B | 648.80M |
| Total liabilities | 1,168,400,000.00 | 1,443,300,000.00 | 1,608,800,000.00 | 1,654,500,000.00 | 2,218,300,000.00 | 2,273,800,000.00 | 1,973,700,000.00 | 1,606,600,000.00 |
| Total equity | 2.79B | 2.42B | 2.55B | 2.32B | 2.21B | 2.26B | 3.40B | 4.25B |
| Retained earnings | 63.10M | -350.20M | -307.90M | -562.20M | -632.40M | -538.30M | 259.40M | 872.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 680.70M | 604.20M | 688.80M | 903.70M | 990.70M | 940.00M |
| Cash & ST investments | 317.30M | 224.80M | 315.30M | 422.90M | 551.20M | 502.40M |
| Inventory | 281.90M | 293.60M | 300.70M | 377.00M | 355.90M | 366.20M |
| Total assets | 5.39B | 5.33B | 5.38B | 5.85B | 5.99B | 5.95B |
| Total current liabilities | 481.90M | 409.90M | 409.10M | 517.10M | 523.30M | 549.00M |
| Short-term debt | 28.00M | 32.60M | 32.80M | 33.30M | 32.50M | 30.90M |
| Long-term debt | 1.02B | 1.06B | 971.00M | 648.80M | 548.90M | 449.10M |
| Total liabilities | 1,926,300,000.00 | 1,892,900,000.00 | 1,794,500,000.00 | 1,606,600,000.00 | 1,566,300,000.00 | 1,511,300,000.00 |
| Total equity | 3.46B | 3.43B | 3.58B | 4.25B | 4.43B | 4.44B |
| Retained earnings | 299.10M | 326.90M | 466.30M | 872.60M | 1.25B | 1.48B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 191.10M | 363.00M | 347.60M | 285.00M | 408.70M | 159.40M | 486.00M | 1.14B |
| Depreciation & amortization | 266.20M | 276.60M | 268.00M | 273.50M | 242.00M | 221.70M | 275.00M | 420.90M |
| Free cash flow | -116.80M | 109.80M | 54.50M | -254.30M | -335.90M | -749.00M | -73.10M | 841.00M |
| Dividends paid | 0 | 0 | 0 | -- | -- | 0 | 0 | 0 |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | 0 | 293.40M | -39.30M |
| Ending cash balance | 615.10M | 830.60M | 941.50M | 544.90M | 407.80M | 367.10M | 347.50M | 421.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 74.30M | 85.80M | 280.80M | 701.70M | 569.90M | 445.10M |
| Depreciation & amortization | 79.70M | 95.00M | 109.90M | 136.30M | 115.70M | 118.60M |
| Free cash flow | 9.40M | 5.60M | 214.30M | 611.70M | 460.70M | 316.10M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | 6.90M | 0 | 0 | -46.20M | -246.80M | -147.90M |
| Ending cash balance | 316.60M | 223.80M | 314.30M | 421.90M | 550.20M | 501.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -1.02 | -16.25 | 1.77 | -10.83 | -3.21 | 4.35 | 29.57 | 17.65 |
| ROA %i | -0.71 | -10.55 | 1.06 | -6.26 | -1.67 | 2.10 | 16.54 | 11.84 |
| ROIC %i | -1.14 | -13.95 | 1.47 | -8.95 | -2.59 | 1.49 | 20.98 | 15.59 |
| 5-year avg ROE %i | -3.90 | -5.63 | 1.41 | -1.26 | -5.91 | -4.83 | 4.33 | 7.51 |
| EBIT margin %i | 1.89 | -30.06 | 8.69 | -27.75 | 4.35 | 9.49 | 59.68 | 37.68 |
| FCF / sales %i | -- | 10.48 | 4.39 | -- | -- | -- | -- | 29.48 |
| Current ratioi | 4.78 | 4.75 | 4.17 | 1.64 | 2.35 | 1.19 | 1.21 | 1.75 |
| Quick ratioi | 3.51 | 3.36 | 3.07 | 1.03 | 0.76 | 0.69 | 0.70 | 0.94 |
| Debt / assetsi | 10.30 | 12.10 | 12.84 | 13.34 | 22.43 | 20.98 | 21.46 | 13.02 |
| LT debt / equityi | 14.84 | 19.15 | 20.65 | 22.37 | 45.93 | 41.98 | 33.67 | 17.38 |
| Interest coveragei | 7.78 | -39.53 | 11.86 | -- | -- | -2.72 | -374.85 | 10.24 |
| Revenue CAGR (3Y) %i | 6.61 | 2.57 | 4.28 | -7.63 | -3.45 | -7.36 | 23.10 | 43.83 |
| Net income CAGR (3Y) %i | -- | -- | -56.04 | -- | -- | 30.33 | -- | -- |
| FCF CAGR (3Y) %i | -- | 58.64 | -11.97 | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 28.42 | 26.28 | 10.09 | 17.65 | 26.00 | 29.53 |
| ROA %i | 15.99 | 15.48 | 6.29 | 11.84 | 17.65 | 20.50 |
| ROIC %i | 20.97 | 20.30 | 9.34 | 15.59 | 22.37 | 25.24 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 56.55 | 54.33 | 28.85 | 37.68 | 44.25 | 45.99 |
| FCF / sales %i | 0.65 | 1.59 | 9.44 | 29.48 | 37.94 | 43.53 |
| Current ratioi | 1.41 | 1.47 | 1.68 | 1.75 | 1.89 | 1.71 |
| Quick ratioi | 0.79 | 0.70 | 0.84 | 0.94 | 1.11 | 0.97 |
| Debt / assetsi | 21.31 | 22.37 | 20.30 | 13.02 | 10.86 | 9.07 |
| LT debt / equityi | 33.03 | 33.76 | 29.69 | 17.38 | 14.27 | 11.57 |
| Interest coveragei | 36.55 | 18.11 | 9.32 | 10.24 | 16.90 | 22.52 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Essakane is the largest reported line at 50.66% of revenue, across 3 reported segments.
- Cote Gold follows at 34.22%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Essakane50.66%
Cote Gold34.22%
Westwood complex15.12%
Quote time 2026-10-08 08:30:11 · For reference only, not investment advice and not tailored to your situation.